Eloria vs Willow

Neither Eloria nor Willow has an FDA warning letter on record. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $299 at Eloria and $299 at Willow.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Eloria / Willow

Eloria logo

Eloria

6.5/10

Willow logo

Willow

7.3/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$299/moCompounded semaglutide injection
$299/moCompounded semaglutide injection
States
No state list published
35 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026

Neither Eloria nor Willow pays us. Links to them earn nothing. Scores: Eloria 6.5, Willow 7.3. How we are paid

What the record shows

  1. 01

    Neither Eloria nor Willow has an FDA warning letter on record.

  2. 02

    Willow names five pharmacies. Eloria names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $299 at Eloria and $299 at Willow.

  4. 04

    Willow lists 35 states. Eloria publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Eloria

Willow

Compounded semaglutide injection

$299/mo

$3,588 a year

$299/mo

$3,588 a year

Compounded tirzepatide injection

$399/mo

$4,788 a year

$399/mo

$4,788 a year

Price includes
Medication, clinician visits, shipping, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Month-to-month has none; longer plans are paid in advance
None
Refunds
Full refund before an order reaches the pharmacy; prepaid plans refunded minus the 3-month price per package sent
Full refund if you cancel before the prescription is sent to the pharmacy; none once the medication is compounded
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Eloria: October 17, 2026. Willow: July 10, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Eloria

6.5/10

The record gives Eloria no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list

The case for Willow

7.3/10
  • Names its compounding pharmacy

Scores

Eloria 6.5 · Willow 7.3 out of 10. Six weighted parts.

Value25%

2.1A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
9.0

Accessibility10%

5.0A
vs
B
7.6

Support10%

8.5A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Eloria vs Willow: questions

Neither Eloria nor Willow has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Willow names five pharmacies. Eloria names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Neither, by more than $1 a month. Eloria charges $299 a month and Willow $299 a month.
Eloria states you can cancel at any time; refunds: full refund before an order reaches the pharmacy; prepaid plans refunded minus the 3-month price per package sent. Willow states you can cancel at any time; refunds: full refund if you cancel before the prescription is sent to the pharmacy; none once the medication is compounded.
Neither Eloria nor Willow pays us. Links to them earn nothing. Scores: Eloria 6.5, Willow 7.3.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register